EVOLUTION OF B PRECURSOR LEUKEMIA IN THE EU-RET MOUSE
EVOLUTION OF B PRECURSOR LEUKEMIA IN THE EU-RET MOUSE
批准号:
6522280
负责人:
STEPHAN A. GRUPP
金额:
$24.14万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-09-30 至 2004-07-31
关键词:
B lymphocyte apoptosis carcinogenesis cell growth regulation cell proliferation embryo /fetus cell /tissue gene expression genetic susceptibility genetically modified animals immunoprecipitation interferons interleukin 7 laboratory mouse leukemia neoplastic growth neoplastic transformation phosphorylation transfection tyrosine
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (adapted verbatim from the investigator's abstract) The E(-ret
mouse carries a transgene that produces a chimeric protein, Rfp-Ret with
constitutive tyrosine kinase activity in B lineage cells. Adult E(-ret mice
develop B precursor leukemias that appear to arise from the progeny of
fetal-derived pro B cells. Furthermore, the leukemias are resistant to stimuli
that induce apoptosis in the pro B cells from fetal and young E(-ret mice. The
applicant hypothesizes that the Rfp-Ret product selectively enhances the
proliferation and survival of fetal-derived pro B cells, and that
transformation is dependent on the accumulation of other mutations which
further enhance these growth properties. The goals of this proposal are to more
thoroughly characterize the multistep process of leukemogenesis in the E(-ret
mouse. In aim 1, he will establish whether fetal and adult pro B cells differ
in their susceptibility to transformation by the Rfp-Ret transgene product. He
will transfer fetal and adult E(-ret pro B cells into Rag-1- mice to determine
whether these populations differ in their ability to induce leukemia. In aim 2,
he will establish whether Rfp-Ret activity mimics the effect of bone marrow
stromal contact. He will determine whether pro B cells from Rag-1- mice acquire
the ability to grow in IL-7 without stromal cell contact when they express the
Rfp-Ret product (E(-ret/Rag-1-), and will determine whether Rfp-Ret enhances
the proliferative effect of IL-7. In aim 3, he will establish whether the
development of interferon (IFN)-( resistance in pro B cells allows for
malignant outgrowth. He will isolate IFN-( resistant cells from within the late
pro B cell populations of healthy adult E(-ret mice, and sequence the
rearranged immunoglobulin heavy chain loci of the IFN-( resistant cells to
determine whether these cells represent a polyclonal (nontransformed) or clonal
(transformed) outgrowth. In aim 4, he will establish whether the level of
Rfp-Ret activity increases during the transformation process. He will
immunoprecipitate Rfp-Ret from the pro B cell populations of fetal and healthy
adult E(-ret mice as well as from leukemias and compare the levels of tyrosine
phophorylation of Rfp-Ret and Rfp-Ret-bound proteins.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The cell and gene therapy toolkit for junior faculty
-
批准号:9903575
-
项目类别:
-
资助金额:$31.97万
-
财政年份:2020
-
负责人:STEPHAN A. GRUPP
-
依托单位:
The cell and gene therapy toolkit for junior faculty
-
批准号:10380059
-
项目类别:
-
资助金额:$33.87万
-
财政年份:2020
-
负责人:STEPHAN A. GRUPP
-
依托单位:
Determinants of Relapse Risk After BMT for ALL
-
批准号:7618461
-
项目类别:
-
资助金额:$29.78万
-
财政年份:2007
-
负责人:STEPHAN A. GRUPP
-
依托单位:
Determinants of Relapse Risk After BMT for ALL
-
批准号:8089570
-
项目类别:
-
资助金额:$29.37万
-
财政年份:2007
-
负责人:STEPHAN A. GRUPP
-
依托单位:
Determinants of Relapse Risk After BMT for ALL
-
批准号:7406724
-
项目类别:
-
资助金额:$28.96万
-
财政年份:2007
-
负责人:STEPHAN A. GRUPP
-
依托单位:
Determinants of Relapse Risk After BMT for ALL
-
批准号:7260150
-
项目类别:
-
资助金额:$30.42万
-
财政年份:2007
-
负责人:STEPHAN A. GRUPP
-
依托单位:
Determinants of Relapse Risk After BMT for ALL
-
批准号:7843565
-
项目类别:
-
资助金额:$30.33万
-
财政年份:2007
-
负责人:STEPHAN A. GRUPP
-
依托单位:
USE OF mTOR INHIBITORS IN B CELL LEUKEMIA
-
批准号:7424976
-
项目类别:
-
资助金额:$31.16万
-
财政年份:2005
-
负责人:STEPHAN A. GRUPP
-
依托单位:
USE OF mTOR INHIBITORS IN B CELL LEUKEMIA
-
批准号:6920407
-
项目类别:
-
资助金额:$30.67万
-
财政年份:2005
-
负责人:STEPHAN A. GRUPP
-
依托单位:
USE OF mTOR INHIBITORS IN B CELL LEUKEMIA
-
批准号:7230434
-
项目类别:
-
资助金额:$30.85万
-
财政年份:2005
-
负责人:STEPHAN A. GRUPP
-
依托单位:
USE OF mTOR INHIBITORS IN B CELL LEUKEMIA
-
批准号:7617848
-
项目类别:
-
资助金额:$32.1万
-
财政年份:2005
-
负责人:STEPHAN A. GRUPP
-
依托单位:
USE OF mTOR INHIBITORS IN B CELL LEUKEMIA
-
批准号:7054784
-
项目类别:
-
资助金额:$30.85万
-
财政年份:2005
-
负责人:STEPHAN A. GRUPP
-
依托单位:
POST TRANSPLANT T CELL RECONSTITUTION IN NEUROBLASTOMA
-
批准号:6929918
-
项目类别:
-
资助金额:$32.18万
-
财政年份:2004
-
负责人:STEPHAN A. GRUPP
-
依托单位:
POST TRANSPLANT T CELL RECONSTITUTION IN NEUROBLASTOMA
-
批准号:6836914
-
项目类别:
-
资助金额:$33.88万
-
财政年份:2004
-
负责人:STEPHAN A. GRUPP
-
依托单位:
EVOLUTION OF B PRECURSOR LEUKEMIA IN THE EU-RET MOUSE
-
批准号:6377289
-
项目类别:
-
资助金额:$23.37万
-
财政年份:1999
-
负责人:STEPHAN A. GRUPP
-
依托单位:
EVOLUTION OF B PRECURSOR LEUKEMIA IN THE EU-RET MOUSE
-
批准号:6609793
-
项目类别:
-
资助金额:$24.38万
-
财政年份:1999
-
负责人:STEPHAN A. GRUPP
-
依托单位:
EVOLUTION OF B PRECURSOR LEUKEMIA IN THE EU-RET MOUSE
-
批准号:6173574
-
项目类别:
-
资助金额:$22.69万
-
财政年份:1999
-
负责人:STEPHAN A. GRUPP
-
依托单位:
EVOLUTION OF B PRECURSOR LEUKEMIA IN THE EU-RET MOUSE
-
批准号:2881528
-
项目类别:
-
资助金额:$19.21万
-
财政年份:1999
-
负责人:STEPHAN A. GRUPP
-
依托单位:
Pediatric Oncology Program
-
批准号:10550223
-
项目类别:
-
资助金额:$8.29万
-
财政年份:1997
-
负责人:STEPHAN A. GRUPP
-
依托单位:
Pediatric Oncology Program
-
批准号:10330968
-
项目类别:
-
资助金额:$8.42万
-
财政年份:1997
-
负责人:STEPHAN A. GRUPP
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: